Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development

Title
Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development
Authors
Keywords
Shp2, SUMOylation, Gab1, ERK activation, hepatocellular carcinoma (HCC)
Journal
Oncotarget
Volume 6, Issue 11, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-15
DOI
10.18632/oncotarget.3323

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started